Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rücker

Showing results (681-690 of 726) with videos related to

Pageof 73
Sort By:
Bone Marrow Transplantation|October 8, 2020
Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trialKristina Hölig, Helmuth Schmidt, Gero Hütter, et al.
Trials|November 15, 2024
The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trialAnna Horn, Julia Wendel, Isabella Franke, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|May 6, 2022
Feasibility and acceptability of using the novel urine-based FujiLAM test to detect tuberculosis: A multi-country mixed-methods studySekai Chenai Mathabire Rücker, Pascale Lissouba, Milcah Akinyi, et al.
JAMA Network Open|January 4, 2022
Feasibility of SARS-CoV-2 Surveillance Testing Among Children and Childcare Workers at German Day Care Centers: A Nonrandomized Controlled TrialJohannes Forster, Andrea Streng, Paul Rudolph, et al.
The Lancet. Neurology|July 17, 2023
The structured ambulatory post-stroke care program for outpatient aftercare in patients with ischaemic stroke in Germany (SANO): an open-label, cluster-randomised controlled trialChristopher J Schwarzbach, Felizitas Anna Eichner, Viktoria Rücker, et al.
Frontiers in Immunology|June 25, 2025
Protective effects for HLA-B*40:01 and C*03:04 in NPM1-mutated AML: result of a large HLA association studyElke Rücker-Braun, Bose Falk, Henning Baldauf, et al.
Blood|May 25, 2013
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemiaJan Krönke, Lars Bullinger, Veronica Teleanu, et al.
Science Advances|April 12, 2024
The autism susceptibility kinase, TAOK2, phosphorylates eEF2 and modulates translationMelad Henis, Tabitha Rücker, Robin Scharrenberg, et al.
Blood|September 15, 2012
Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicingAnna Dolnik, Julia C Engelmann, Maren Scharfenberger-Schmeer, et al.
BMC Neurology|March 21, 2020
Two years' experience of implementing a comprehensive telemedical stroke network comprising in mainly rural region: the Transregional Network for Stroke Intervention with Telemedicine (TRANSIT-Stroke)Katharina M A Gabriel, Steffi Jírů-Hillmann, Peter Kraft, et al.
Pageof 73

Showing results (681-690 of 726) with videos related to

Sort By:
Pageof 73
Bone Marrow Transplantation|October 8, 2020
Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trialKristina Hölig, Helmuth Schmidt, Gero Hütter, et al.
Trials|November 15, 2024
The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trialAnna Horn, Julia Wendel, Isabella Franke, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|May 6, 2022
Feasibility and acceptability of using the novel urine-based FujiLAM test to detect tuberculosis: A multi-country mixed-methods studySekai Chenai Mathabire Rücker, Pascale Lissouba, Milcah Akinyi, et al.
JAMA Network Open|January 4, 2022
Feasibility of SARS-CoV-2 Surveillance Testing Among Children and Childcare Workers at German Day Care Centers: A Nonrandomized Controlled TrialJohannes Forster, Andrea Streng, Paul Rudolph, et al.
The Lancet. Neurology|July 17, 2023
The structured ambulatory post-stroke care program for outpatient aftercare in patients with ischaemic stroke in Germany (SANO): an open-label, cluster-randomised controlled trialChristopher J Schwarzbach, Felizitas Anna Eichner, Viktoria Rücker, et al.
Frontiers in Immunology|June 25, 2025
Protective effects for HLA-B*40:01 and C*03:04 in NPM1-mutated AML: result of a large HLA association studyElke Rücker-Braun, Bose Falk, Henning Baldauf, et al.
Blood|May 25, 2013
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemiaJan Krönke, Lars Bullinger, Veronica Teleanu, et al.
Science Advances|April 12, 2024
The autism susceptibility kinase, TAOK2, phosphorylates eEF2 and modulates translationMelad Henis, Tabitha Rücker, Robin Scharrenberg, et al.
Blood|September 15, 2012
Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicingAnna Dolnik, Julia C Engelmann, Maren Scharfenberger-Schmeer, et al.
BMC Neurology|March 21, 2020
Two years' experience of implementing a comprehensive telemedical stroke network comprising in mainly rural region: the Transregional Network for Stroke Intervention with Telemedicine (TRANSIT-Stroke)Katharina M A Gabriel, Steffi Jírů-Hillmann, Peter Kraft, et al.
Pageof 73